Inflammatory Bowel Disease in a Patient Returning from Colombia: Association with Dipeptidyl Peptidase 4 Inhibitor?
This case underscores the importance of considering IBD secondary to DPP-4 inhibitor use in the evaluation of patients with recent-onset IBD. Further research is needed to elucidate the pathophysiological mechanisms underlying the relationship between DPP-4 inhibitors and IBD.
Authors
- Nanne K.H. de Boer (ORCID: https://orcid.org/0000-0001-8357-9887)
- Dirk Jan Stenvers (ORCID: https://orcid.org/0000-0002-9519-5140)
- Andra Neefjes‐Borst (ORCID: https://orcid.org/0000-0001-7945-7916)
- Gwen Masclee (ORCID: https://orcid.org/0000-0002-2839-027X)
- Ahmed B. Bayoumy (ORCID: https://orcid.org/0000-0002-5302-9312)
Institutions
- Amsterdam UMC Location University of Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Case Reports in Gastroenterology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1159/000543680
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29